峆一药业 — Investor Relations & Filings
About 峆一药业
Anhui Heyi Pharmaceutical Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality chemical products for various therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. With a strong emphasis on technological innovation and quality control, it operates advanced manufacturing facilities that adhere to international standards. Its product portfolio includes key intermediates for widely used medications, supporting both domestic and global pharmaceutical supply chains. The company leverages its expertise in complex chemical synthesis to offer customized solutions and reliable supply to its partners in the life sciences sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度独立董事述职报告(杨模荣) | 2026-04-15 | Chinese | |
| 2025年年度报告摘要 | 2026-04-15 | Chinese | |
| 2025年年度报告 | 2026-04-15 | Chinese | |
| 国元证券股份有限公司关于安徽峆一药业股份有限公司2025年度持续督导跟踪报告 | 2026-04-15 | Chinese | |
| 审计报告 | 2026-04-15 | Chinese | |
| 关于公司及子公司拟向银行申请综合授信额度的公告 | 2026-04-15 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39661619 | 2025年度独立董事述职报告(杨模荣) | 2026-04-15 | Chinese | ||
| 39661616 | 2025年年度报告摘要 | 2026-04-15 | Chinese | ||
| 39661615 | 2025年年度报告 | 2026-04-15 | Chinese | ||
| 39661612 | 国元证券股份有限公司关于安徽峆一药业股份有限公司2025年度持续督导跟踪报告 | 2026-04-15 | Chinese | ||
| 39661607 | 审计报告 | 2026-04-15 | Chinese | ||
| 39661600 | 关于公司及子公司拟向银行申请综合授信额度的公告 | 2026-04-15 | Chinese | ||
| 39661598 | 拟续聘2026年度会计师事务所公告 | 2026-04-15 | Chinese | ||
| 39661597 | 国元证券股份有限公司关于安徽峆一药业股份有限公司使用闲置募集资金进行现金管理的核查意见 | 2026-04-15 | Chinese | ||
| 39661594 | 使用闲置募集资金进行现金管理公告 | 2026-04-15 | Chinese | ||
| 39661590 | 关于为全资子公司提供担保的公告 | 2026-04-15 | Chinese | ||
| 39661589 | 2025年年度权益分派预案公告 | 2026-04-15 | Chinese | ||
| 39661588 | 董事会审计委员会对会计师事务所2025年度履行监督职责情况报告 | 2026-04-15 | Chinese | ||
| 39661587 | 关于召开2025年年度股东会通知公告(提供网络投票) | 2026-04-15 | Chinese | ||
| 39661583 | 2025年度独立董事述职报告(潘平) | 2026-04-15 | Chinese | ||
| 39661582 | 国元证券股份有限公司关于安徽峆一药业股份有限公司2025年度募集资金存放、管理与实际使用情况的专项核查意见 | 2026-04-15 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
峆一药业 via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58845/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58845 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58845 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58845 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58845}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 峆一药业 (id: 58845)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.